Friday, January 27, 2017

UPDATE 1-Drugmaker AbbVie's quarterly revenue misses estimates

Jan 27 (Reuters) - AbbVie Inc's quarterly adjusted

revenue missed analysts' estimate, in part due to

lower-than-expected sales of its hepatitis C drug and cancer

treatment.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)